newsfilter
← Latest News
GlobeNewswire·

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

WESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S. Food and Drug